Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.
2.

Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer.

Livi V, Ardizzoni A, Cancellieri A, Natali F, Ferrari M, Paioli D, De Biase D, Capizzi E, Tallini G, Fiorentino M, Trisolini R.

Clin Respir J. 2019 Sep;13(9):590-597. doi: 10.1111/crj.13063. Epub 2019 Aug 9.

PMID:
31343834
3.

Concordance, intra- and inter-observer agreements between light microscopy and whole slide imaging for samples acquired by EUS in pancreatic solid lesions.

Larghi A, Fornelli A, Lega S, Ragazzi M, Carlinfante G, Baccarini P, Fabbri C, Pierotti P, Tallini G, Bondi A, de Biase D.

Dig Liver Dis. 2019 May 27. pii: S1590-8658(19)30584-5. doi: 10.1016/j.dld.2019.04.019. [Epub ahead of print]

PMID:
31147212
4.

BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma.

Repaci A, Vicennati V, Paccapelo A, Cavicchi O, Salituro N, Monari F, de Biase D, Tallini G, Altimari A, Gruppioni E, Fiorentino M, Pagotto U.

Int J Endocrinol. 2019 Apr 7;2019:3081497. doi: 10.1155/2019/3081497. eCollection 2019.

5.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.

Pisapia P, Malapelle U, Roma G, Saddar S, Zheng Q, Pepe F, Bruzzese D, Vigliar E, Bellevicine C, Luthra R, Nikiforov YE, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Bihl M, Savic S, Bubendorf L, de Biase D, Tallini G, Hwang DH, Sholl LM, Vander Borght S, Weynand B, Stieber D, Vielh P, Rappa A, Barberis M, Fassan M, Rugge M, De Andrea CE, Lozano MD, Lupi C, Fontanini G, Schmitt F, Dumur CI, Bisig B, Bongiovanni M, Merkelbach-Bruse S, Büttner R, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2019 May;127(5):285-296. doi: 10.1002/cncy.22134. Epub 2019 Apr 25.

PMID:
31021538
6.

Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases.

Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S, Fedele M, Battista S, Verde P, Santoro M, Fusco A.

Clin Cancer Res. 2019 Apr 15;25(8):2675. doi: 10.1158/1078-0432.CCR-19-0487. No abstract available.

PMID:
30988099
7.

Invited review-next-generation sequencing: a modern tool in cytopathology.

Roy-Chowdhuri S, Pisapia P, Salto-Tellez M, Savic S, Nacchio M, de Biase D, Tallini G, Troncone G, Schmitt F.

Virchows Arch. 2019 Jul;475(1):3-11. doi: 10.1007/s00428-019-02559-z. Epub 2019 Mar 15. Review.

PMID:
30877381
8.

Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.

Xu B, Reznik E, Tuttle RM, Knauf J, Fagin JA, Katabi N, Dogan S, Aleynick N, Seshan V, Middha S, Enepekides D, Casadei GP, Solaroli E, Tallini G, Ghossein R, Ganly I.

Endocrine. 2019 Apr;64(1):97-108. doi: 10.1007/s12020-019-01848-6. Epub 2019 Jan 28.

PMID:
30689169
9.

Not the same thing: metastatic PTCs have a different background than ATCs.

de Biase D, Torricelli F, Ragazzi M, Donati B, Khun E, Visani M, Acquaviva G, Pession A, Tallini G, Piana S, Ciarrocchi A.

Endocr Connect. 2018 Nov 1. pii: EC-18-0386.R2. doi: 10.1530/EC-18-0386. [Epub ahead of print]

10.

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA.

Mod Pathol. 2018 Dec;31(12):1770-1786. doi: 10.1038/s41379-018-0110-y. Epub 2018 Aug 23.

11.
12.

Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.

Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D'Errico A, de Biase D.

World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647. Review.

13.

The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?

Franceschi E, Mura A, De Biase D, Tallini G, Pession A, Foschini MP, Danieli D, Pizzolitto S, Zunarelli E, Lanza G, Bartolini D, Silini EM, Visani M, Di Oto E, Tosoni A, Minichillo S, Lamberti G, Lanese A, Paccapelo A, Bartolini S, Brandes AA.

Future Oncol. 2018 Jul;14(16):1559-1567. doi: 10.2217/fon-2017-0634. Epub 2018 Jun 25.

PMID:
29938525
14.

Temozolomide rechallenge in recurrent glioblastoma: when is it useful?

Franceschi E, Lamberti G, Visani M, Paccapelo A, Mura A, Tallini G, Pession A, De Biase D, Minichillo S, Tosoni A, Di Battista M, Cubeddu A, Bartolini S, Brandes AA.

Future Oncol. 2018 May;14(11):1063-1069. doi: 10.2217/fon-2017-0681. Epub 2018 May 9.

PMID:
29741106
15.

The Role of Next-Generation Sequencing in the Cytologic Diagnosis of Pancreatic Lesions.

de Biase D, Visani M, Acquaviva G, Fornelli A, Masetti M, Fabbri C, Pession A, Tallini G.

Arch Pathol Lab Med. 2018 Apr;142(4):458-464. doi: 10.5858/arpa.2017-0215-RA.

PMID:
29565213
16.

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients.

Acquaviva G, Visani M, de Biase D, Marucci G, Franceschi E, Tosoni A, Brandes AA, Rhoden KJ, Pession A, Tallini G.

Sci Rep. 2018 Mar 13;8(1):4459. doi: 10.1038/s41598-018-22222-y.

17.

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.

Gandolfi G, Ragazzi M, de Biase D, Visani M, Zanetti E, Torricelli F, Sancisi V, Gugnoni M, Manzotti G, Braglia L, Cavuto S, Merlo DF, Tallini G, Frasoldati A, Piana S, Ciarrocchi A.

Oncotarget. 2017 Dec 1;9(2):1813-1825. doi: 10.18632/oncotarget.22805. eCollection 2018 Jan 5.

18.

Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?

Xu B, Farhat N, Barletta JA, Hung YP, Biase D, Casadei GP, Onenerk AM, Tuttle RM, Roman BR, Katabi N, Nosé V, Sadow P, Tallini G, Faquin WC, Ghossein R.

Endocrine. 2018 Jan;59(1):143-150. doi: 10.1007/s12020-017-1484-1. Epub 2017 Dec 4.

19.

Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: from the test tube to the operatory room.

Forti Parri SN, Bonfanti B, Cancellieri A, De Biase D, Trisolini R, Zoboli S, Bertolaccini L, Solli P, Tallini G.

Ann Transl Med. 2017 Oct;5(20):397. doi: 10.21037/atm.2017.07.41. Review.

20.

Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.

Masetti M, Acquaviva G, Visani M, Tallini G, Fornelli A, Ragazzi M, Vasuri F, Grifoni D, Di Giacomo S, Fiorino S, Lombardi R, Tuminati D, Ravaioli M, Fabbri C, Bacchi-Reggiani ML, Pession A, Jovine E, de Biase D.

Cancer Biomark. 2018 Feb 6;21(2):323-334. doi: 10.3233/CBM-170464.

PMID:
29103024
21.

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists.

Seethala RR, Baloch ZW, Barletta JA, Khanafshar E, Mete O, Sadow PM, LiVolsi VA, Nikiforov YE, Tallini G, Thompson LD.

Mod Pathol. 2018 Jan;31(1):39-55. doi: 10.1038/modpathol.2017.130. Epub 2017 Oct 20. Review.

22.

Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.

Visani M, Acquaviva G, Marucci G, Paccapelo A, Mura A, Franceschi E, Grifoni D, Pession A, Tallini G, Brandes AA, de Biase D.

J Neurooncol. 2017 Nov;135(2):245-254. doi: 10.1007/s11060-017-2571-0. Epub 2017 Jul 26.

PMID:
28748342
23.

Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors.

Vornetti G, Marucci G, Zenesini C, de Biase D, Michelucci R, Tinuper P, Tallini G, Giulioni M.

J Clin Neurosci. 2017 Oct;44:158-163. doi: 10.1016/j.jocn.2017.06.022. Epub 2017 Jun 30.

PMID:
28673671
24.

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.

de Biase D, Genestreti G, Visani M, Acquaviva G, Di Battista M, Cavallo G, Paccapelo A, Cancellieri A, Trisolini R, Degli Esposti R, Bartolini S, Pession A, Tallini G, Brandes AA.

PLoS One. 2017 May 16;12(5):e0177822. doi: 10.1371/journal.pone.0177822. eCollection 2017.

25.

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2017 Aug;125(8):615-626. doi: 10.1002/cncy.21868. Epub 2017 May 5.

26.

Clival chordomas: considerations after 16 years of endoscopic endonasal surgery.

Zoli M, Milanese L, Bonfatti R, Faustini-Fustini M, Marucci G, Tallini G, Zenesini C, Sturiale C, Frank G, Pasquini E, Mazzatenta D.

J Neurosurg. 2018 Feb;128(2):329-338. doi: 10.3171/2016.11.JNS162082. Epub 2017 Apr 14.

PMID:
28409727
27.

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.

Xu B, Tallini G, Ghossein RA.

Endocr Pathol. 2017 Jun;28(2):128-138. doi: 10.1007/s12022-017-9478-3. Review. Retraction in: Endocr Pathol. 2018 Aug 7;:.

PMID:
28361392
28.

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

Brandes AA, Franceschi E, Paccapelo A, Tallini G, De Biase D, Ghimenton C, Danieli D, Zunarelli E, Lanza G, Silini EM, Sturiale C, Volpin L, Servadei F, Talacchi A, Fioravanti A, Pia Foschini M, Bartolini S, Pession A, Ermani M.

Oncologist. 2017 Apr;22(4):432-437. doi: 10.1634/theoncologist.2016-0254. Epub 2017 Mar 8.

29.

Team work and cytopathology molecular diagnosis of solid pancreatic lesions.

Fabbri C, Gibiino G, Fornelli A, Cennamo V, Grifoni D, Visani M, Acquaviva G, Fassan M, Fiorino S, Giovanelli S, Bassi M, Ghersi S, Tallini G, Jovine E, Gasbarrini A, de Biase D.

Dig Endosc. 2017 Sep;29(6):657-666. doi: 10.1111/den.12845. Epub 2017 Mar 16. Review.

PMID:
28190274
30.

Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma.

Genestreti G, de Biase D, Di Battista M, Cavallo G, Degli Esposti R, Visani M, Acquaviva G, Brand T, Pession A, Tallini G, Brandes AA.

Clin Lung Cancer. 2017 May;18(3):e215-e217. doi: 10.1016/j.cllc.2017.01.003. Epub 2017 Jan 11. No abstract available.

PMID:
28162944
31.

Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein RA.

Thyroid. 2017 Apr;27(4):512-517. doi: 10.1089/thy.2016.0649. Epub 2017 Feb 24.

32.

Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas.

Zoli M, Sambati L, Milanese L, Foschi M, Faustini-Fustini M, Marucci G, de Biase D, Tallini G, Cecere A, Mignani F, Sturiale C, Frank G, Pasquini E, Cortelli P, Mazzatenta D, Provini F.

Neurosurg Focus. 2016 Dec;41(6):E12.

PMID:
27903128
33.

The History of the Follicular Variant of Papillary Thyroid Carcinoma.

Tallini G, Tuttle RM, Ghossein RA.

J Clin Endocrinol Metab. 2017 Jan 1;102(1):15-22. doi: 10.1210/jc.2016-2976. Review.

PMID:
27732333
34.

RET mutation and increased angiogenesis in medullary thyroid carcinomas.

Verrienti A, Tallini G, Colato C, Boichard A, Checquolo S, Pecce V, Sponziello M, Rosignolo F, de Biase D, Rhoden K, Casadei GP, Russo D, Visani M, Acquaviva G, Ferdeghini M, Filetti S, Durante C.

Endocr Relat Cancer. 2016 Aug;23(8):665-76. doi: 10.1530/ERC-16-0132. Epub 2016 Jul 8.

PMID:
27402614
35.

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A.

Oncogene. 2016 Sep 29;35(39):5214. doi: 10.1038/onc.2016.139. Epub 2016 Jun 27. No abstract available.

PMID:
27345412
36.

Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.

de Biase D, de Luca C, Gragnano G, Visani M, Bellevicine C, Malapelle U, Tallini G, Troncone G.

J Clin Pathol. 2016 Apr 27. pii: jclinpath-2016-203696. doi: 10.1136/jclinpath-2016-203696. [Epub ahead of print]

PMID:
27122185
37.

Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.

Maletta F, Massa F, Torregrossa L, Duregon E, Casadei GP, Basolo F, Tallini G, Volante M, Nikiforov YE, Papotti M.

Hum Pathol. 2016 Aug;54:134-42. doi: 10.1016/j.humpath.2016.03.014. Epub 2016 Apr 13.

38.

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA.

JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.

39.

NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.

Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.

Cancer. 2016 Apr 1;122(7):1097-107. doi: 10.1002/cncr.29887. Epub 2016 Jan 19.

40.

Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review.

Farina E, Monari F, Tallini G, Repaci A, Mazzarotto R, Giunchi F, Panzacchi R, Cammelli S, Padula GD, Deodato F, Pasquali R, Fanti S, Fiorentino M, Morganti AG.

Endocr Pathol. 2016 Mar;27(1):55-64. doi: 10.1007/s12022-015-9410-7. Review.

PMID:
26662609
41.

Search for HBV and HCV Genome in Cancer Cells of Pancreatic Tumors.

Fiorino S, Visani M, Acquaviva G, Fornelli A, Masetti M, Cuppini A, Bacchi-Reggiani ML, Jovine E, Tallini G, Pession A, de Biase D.

Pancreas. 2016 Jan;45(1):e12-4. doi: 10.1097/MPA.0000000000000467. No abstract available.

PMID:
26658043
42.

Pathological spectrum in recurrences of glioblastoma multiforme.

Marucci G, Fabbri PV, Morandi L, De Biase D, Di Oto E, Tallini G, Sturiale C, Franceschi E, Frezza GP, Foschini MP.

Pathologica. 2015 Mar;107(1):1-8.

PMID:
26591624
43.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.

44.

Erratum to: Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.

Marucci G, de Biase D, Zoli M, Faustini-Fustini M, Bacci A, Pasquini E, Visani M, Mazzatenta D, Frank G, Tallini G.

Pituitary. 2016 Feb;19(1):113. doi: 10.1007/s11102-015-0683-0. No abstract available.

PMID:
26450712
45.

Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.

Dima M, Pecce V, Biffoni M, Di Gioia CR, Tallini G, Biffoni M, Rosignolo F, Verrienti A, Sponziello M, Damante G, Russo D, Durante C.

Endocrine. 2016 Jul;53(1):145-56. doi: 10.1007/s12020-015-0739-y. Epub 2015 Sep 14.

PMID:
26370117
46.

Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.

Visani M, Acquaviva G, Fiorino S, Bacchi Reggiani ML, Masetti M, Franceschi E, Fornelli A, Jovine E, Fabbri C, Brandes AA, Tallini G, Pession A, de Biase D.

J Clin Pathol. 2015 Nov;68(11):859-69. doi: 10.1136/jclinpath-2015-203246. Epub 2015 Aug 27. Review.

PMID:
26314585
47.

BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, Bacchi Reggiani ML, Casadei GP, Costante G, Cremonini N, Lamartina L, Meringolo D, Nardi F, Pession A, Rhoden KJ, Ronga G, Torlontano M, Verrienti A, Visani M, Filetti S.

Mod Pathol. 2015 Oct;28(10):1343-59. doi: 10.1038/modpathol.2015.92. Epub 2015 Aug 14.

48.

High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.

Kurelac I, de Biase D, Calabrese C, Ceccarelli C, Ng CK, Lim R, MacKay A, Weigelt B, Porcelli AM, Reis-Filho JS, Tallini G, Gasparre G.

Am J Cancer Res. 2015 May 15;5(6):1954-71. eCollection 2015.

49.

Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.

Trisolini R, Cancellieri A, Tinelli C, de Biase D, Valentini I, Casadei G, Paioli D, Ferrari F, Gordini G, Patelli M, Tallini G.

Chest. 2015 Dec;148(6):1430-1437. doi: 10.1378/chest.15-0583.

PMID:
26158441
50.

Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.

Marucci G, de Biase D, Zoli M, Faustini-Fustini M, Bacci A, Pasquini E, Visani M, Mazzatenta D, Frank G, Tallini G.

Pituitary. 2015 Dec;18(6):905-11. doi: 10.1007/s11102-015-0669-y. Erratum in: Pituitary. 2016 Feb;19(1):113.

PMID:
26156055

Supplemental Content

Loading ...
Support Center